GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shandong Weigao Group Medical Polymer Co Ltd (HKSE:01066) » Definitions » EBITDA Margin %

Shandong Weigao Group Medical Polymer Co (HKSE:01066) EBITDA Margin % : 23.29% (As of Jun. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Shandong Weigao Group Medical Polymer Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Shandong Weigao Group Medical Polymer Co's EBITDA for the six months ended in Jun. 2023 was HK$1,757 Mil. Shandong Weigao Group Medical Polymer Co's Revenue for the six months ended in Jun. 2023 was HK$7,545 Mil. Therefore, Shandong Weigao Group Medical Polymer Co's EBITDA margin for the quarter that ended in Jun. 2023 was 23.29%.


Shandong Weigao Group Medical Polymer Co EBITDA Margin % Historical Data

The historical data trend for Shandong Weigao Group Medical Polymer Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Weigao Group Medical Polymer Co EBITDA Margin % Chart

Shandong Weigao Group Medical Polymer Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.45 29.71 28.43 31.66 19.97

Shandong Weigao Group Medical Polymer Co Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.00 28.50 22.82 23.29 16.36

Competitive Comparison of Shandong Weigao Group Medical Polymer Co's EBITDA Margin %

For the Medical Instruments & Supplies subindustry, Shandong Weigao Group Medical Polymer Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Weigao Group Medical Polymer Co's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shandong Weigao Group Medical Polymer Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Shandong Weigao Group Medical Polymer Co's EBITDA Margin % falls into.



Shandong Weigao Group Medical Polymer Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Shandong Weigao Group Medical Polymer Co's EBITDA Margin % for the fiscal year that ended in Dec. 2022 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=4815.066/15208.546
=31.66 %

Shandong Weigao Group Medical Polymer Co's EBITDA Margin % for the quarter that ended in Jun. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=1757.173/7544.57
=23.29 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shandong Weigao Group Medical Polymer Co  (HKSE:01066) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Shandong Weigao Group Medical Polymer Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Shandong Weigao Group Medical Polymer Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Weigao Group Medical Polymer Co (HKSE:01066) Business Description

Traded in Other Exchanges
Address
No.1, Weigao Road, Torch Hi-tech Science Park, Shandong Province, Weihai, CHN
Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.

Shandong Weigao Group Medical Polymer Co (HKSE:01066) Headlines

No Headlines